Royal Bank Of Canada Nkarta, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Nkarta, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 5,247 shares of NKTX stock, worth $12,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,247

Previous 5,047 3.96%

Holding current value

$12,330

Previous $29,000 20.69%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.52 - $8.0 $903 - $1,600	200 Added 3.96%	5,247 $23,000
Q2 2024 Aug 14, 2024	BUY	$5.27 - $10.82 $22,618 - $46,439	4,292 Added 568.48%	5,047 $29,000
Q1 2024 Nov 05, 2024	SELL	$5.59 - $15.71 $23,992 - $67,427	-4,292 Reduced 85.04%	755 $8,000
Q1 2024 May 15, 2024	SELL	$5.59 - $15.71 $48,129 - $135,263	-8,610 Reduced 91.94%	755 $8,000
Q4 2023 Feb 14, 2024	BUY	$1.31 - $6.6 $5,617 - $28,300	4,288 Added 84.46%	9,365 $61,000
Q3 2023 Nov 14, 2023	BUY	$1.39 - $2.29 $2,508 - $4,133	1,805 Added 55.17%	5,077 $7,000
Q2 2023 Aug 14, 2023	BUY	$2.19 - $5.17 $2,649 - $6,255	1,210 Added 58.68%	3,272 $7,000
Q1 2023 May 15, 2023	SELL	$3.37 - $6.3 $6,905 - $12,908	-2,049 Reduced 49.84%	2,062 $7,000
Q4 2022 Feb 14, 2023	BUY	$5.14 - $14.35 $17,625 - $49,206	3,429 Added 502.79%	4,111 $24,000
Q3 2022 Nov 14, 2022	BUY	$12.27 - $18.39 $5,141 - $7,705	419 Added 159.32%	682 $9,000
Q2 2022 Aug 15, 2022	SELL	$7.77 - $19.44 $5,314 - $13,296	-684 Reduced 72.23%	263 $3,000
Q1 2022 May 16, 2022	SELL	$8.66 - $14.99 $14,678 - $25,408	-1,695 Reduced 64.16%	947 $11,000
Q4 2021 Feb 14, 2022	BUY	$12.79 - $26.88 $17,650 - $37,094	1,380 Added 109.35%	2,642 $41,000
Q3 2021 Nov 15, 2021	BUY	$26.67 - $38.76 $6,214 - $9,031	233 Added 22.64%	1,262 $35,000
Q2 2021 Aug 16, 2021	BUY	$23.94 - $36.68 $24,634 - $37,743	1,029 New	1,029 $33,000

Others Institutions Holding NKTX

# of Institutions

129

Shares Held

66.5M

Call Options Held

173K

Put Options Held

20K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $114M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Nkarta, Inc. Transaction History